| Dorothy Marie Klingmeyer, DO | |
|
1080 N Green St, Brownsburg, IN 46112-2416 | |
| (317) 386-5628 | |
| (317) 386-5629 |
| Full Name | Dorothy Marie Klingmeyer |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 1080 N Green St, Brownsburg, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487996062 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02006935A (Indiana) | Secondary |
| 204D00000X | Neuromusculoskeletal Medicine & Omm | 02006935A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendricks Regional Health | Danville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Practice Associates Medical Group | 5890703177 | 1116 |
| Hendricks County Hospital | 4880505528 | 274 |
News Archive
More people than ever are able to resume working after a heart attack, but those working less or unable to work reported lower quality of life with increased depression and difficulty affording their medication, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Against a background of high mortality rates from cardiovascular disease (CVD) in Brazil, the European Society of Cardiology (ESC) is to deliver an educational programme at the 66th Annual Congress of the Brazilian Society of Cardiology.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
National data shows a major shift in eye surgeries from hospitals to less expensive ambulatory surgery centers where care may be delivered faster and closer to home for some patients.
› Verified 7 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
More people than ever are able to resume working after a heart attack, but those working less or unable to work reported lower quality of life with increased depression and difficulty affording their medication, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Against a background of high mortality rates from cardiovascular disease (CVD) in Brazil, the European Society of Cardiology (ESC) is to deliver an educational programme at the 66th Annual Congress of the Brazilian Society of Cardiology.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
National data shows a major shift in eye surgeries from hospitals to less expensive ambulatory surgery centers where care may be delivered faster and closer to home for some patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dorothy Marie Klingmeyer, DO 1080 N Green St, Brownsburg, IN 46112-2416 Ph: (317) 386-5628 | Dorothy Marie Klingmeyer, DO 1080 N Green St, Brownsburg, IN 46112-2416 Ph: (317) 386-5628 |
News Archive
More people than ever are able to resume working after a heart attack, but those working less or unable to work reported lower quality of life with increased depression and difficulty affording their medication, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Against a background of high mortality rates from cardiovascular disease (CVD) in Brazil, the European Society of Cardiology (ESC) is to deliver an educational programme at the 66th Annual Congress of the Brazilian Society of Cardiology.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
National data shows a major shift in eye surgeries from hospitals to less expensive ambulatory surgery centers where care may be delivered faster and closer to home for some patients.
› Verified 7 days ago